BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gallati S. Disease-modifying genes and monogenic disorders: experience in cystic fibrosis. Appl Clin Genet. 2014;7:133-146. [PMID: 25053892 DOI: 10.2147/tacg.s18675] [Cited by in Crossref: 55] [Cited by in F6Publishing: 28] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Ramzan S, Tennstedt S, Tariq M, Khan S, Noor Ul Ayan H, Ali A, Munz M, Thiele H, Korejo AA, Mughal AR, Jamal SZ, Nürnberg P, Baig SM, Erdmann J, Ahmad I. A Novel Missense Mutation in TNNI3K Causes Recessively Inherited Cardiac Conduction Disease in a Consanguineous Pakistani Family. Genes (Basel) 2021;12:1282. [PMID: 34440456 DOI: 10.3390/genes12081282] [Reference Citation Analysis]
2 Argmann CA, Houten SM, Zhu J, Schadt EE. A Next Generation Multiscale View of Inborn Errors of Metabolism. Cell Metab 2016;23:13-26. [PMID: 26712461 DOI: 10.1016/j.cmet.2015.11.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 7.9] [Reference Citation Analysis]
3 Kormann MSD, Dewerth A, Eichner F, Baskaran P, Hector A, Regamey N, Hartl D, Handgretinger R, Antony JS. Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity. PLoS One 2017;12:e0183526. [PMID: 28846703 DOI: 10.1371/journal.pone.0183526] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
4 Gohy S, Moeremans A, Pilette C, Collin A. Immunoglobulin A Mucosal Immunity and Altered Respiratory Epithelium in Cystic Fibrosis. Cells 2021;10:3603. [PMID: 34944110 DOI: 10.3390/cells10123603] [Reference Citation Analysis]
5 Veit G, Oliver K, Apaja PM, Perdomo D, Bidaud-Meynard A, Lin ST, Guo J, Icyuz M, Sorscher EJ, Hartman JL IV, Lukacs GL. Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect. PLoS Biol 2016;14:e1002462. [PMID: 27168400 DOI: 10.1371/journal.pbio.1002462] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
6 Townend GS, Ehrhart F, van Kranen HJ, Wilkinson M, Jacobsen A, Roos M, Willighagen EL, van Enckevort D, Evelo CT, Curfs LMG. MECP2 variation in Rett syndrome-An overview of current coverage of genetic and phenotype data within existing databases. Hum Mutat 2018;39:914-24. [PMID: 29704307 DOI: 10.1002/humu.23542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Butnariu LI, Țarcă E, Cojocaru E, Rusu C, Moisă ȘM, Leon Constantin MM, Gorduza EV, Trandafir LM. Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine. J Clin Med 2021;10:5821. [PMID: 34945117 DOI: 10.3390/jcm10245821] [Reference Citation Analysis]
8 de Faria Poloni J, Rispoli T, Rossetti ML, Trindade C, Vargas JE. Cystic Fibrosis: Systems Biology Analysis from Homozygous p.Phe508del Variant Patients' Samples Reveals Perturbations in Tissue-Specific Pathways. Biomed Res Int 2021;2021:5262000. [PMID: 34901273 DOI: 10.1155/2021/5262000] [Reference Citation Analysis]
9 Bonini J, Varilh J, Raynal C, Thèze C, Beyne E, Audrezet MP, Ferec C, Bienvenu T, Girodon E, Tuffery-Giraud S, Des Georges M, Claustres M, Taulan-Cadars M. Small-scale high-throughput sequencing-based identification of new therapeutic tools in cystic fibrosis. Genet Med 2015;17:796-806. [PMID: 25569440 DOI: 10.1038/gim.2014.194] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
10 Roy S, Pal P, Ghosh S, Bhattacharya S, Das SK, Gangopadhyay PK, Bavdekar A, Ray K, Sengupta M, Ray J. Potential Role of Brain-Derived Neurotrophic Factor and Dopamine Receptor D2 Gene Variants as Modifiers for the Susceptibility and Clinical Course of Wilson's Disease. Neuromolecular Med 2018;20:401-8. [PMID: 29992511 DOI: 10.1007/s12017-018-8501-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol 2019;73:1978-86. [PMID: 31000001 DOI: 10.1016/j.jacc.2019.01.061] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 25.0] [Reference Citation Analysis]
12 Sharifi A, Mahdieh N. HBB mutations and HbA2 level: Escaping the carrier screening programs. Clin Case Rep 2021;9:973-7. [PMID: 33598281 DOI: 10.1002/ccr3.3714] [Reference Citation Analysis]
13 Furlan LL, Marson FA, Ribeiro JD, Bertuzzo CS, Salomão Junior JB, Souza DR. IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability. Hum Genet 2016;135:881-94. [PMID: 27209008 DOI: 10.1007/s00439-016-1684-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
14 Chow CY, Kelsey KJ, Wolfner MF, Clark AG. Candidate genetic modifiers of retinitis pigmentosa identified by exploiting natural variation in Drosophila. Hum Mol Genet 2016;25:651-9. [PMID: 26662796 DOI: 10.1093/hmg/ddv502] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
15 Lin SR, Pan CJ, Mansfield BC, Chou JY. Functional analysis of mutations in a severe congenital neutropenia syndrome caused by glucose-6-phosphatase-β deficiency. Mol Genet Metab 2015;114:41-5. [PMID: 25492228 DOI: 10.1016/j.ymgme.2014.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Mitra I, Lavillaureix A, Yeh E, Traglia M, Tsang K, Bearden CE, Rauen KA, Weiss LA. Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders. PLoS Genet 2017;13:e1006516. [PMID: 28076348 DOI: 10.1371/journal.pgen.1006516] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
17 Philp AR, Riquelme TT, Millar-Büchner P, González R, Sepúlveda FV, Cid LP, Flores CA. Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse. Sci Rep 2018;8:9320. [PMID: 29915289 DOI: 10.1038/s41598-018-27465-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
18 Archibald AD, Smith MJ, Burgess T, Scarff KL, Elliott J, Hunt CE, Barns-Jenkins C, Holt C, Sandoval K, Siva Kumar V. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genet Med. 2018;20:513-523. [PMID: 29261177 DOI: 10.1038/gim.2017.134] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
19 Amorim CEG, Gao Z, Baker Z, Diesel JF, Simons YB, Haque IS, Pickrell J, Przeworski M. The population genetics of human disease: The case of recessive, lethal mutations. PLoS Genet 2017;13:e1006915. [PMID: 28957316 DOI: 10.1371/journal.pgen.1006915] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
20 Campbell RF, McGrath PT, Paaby AB. Analysis of Epistasis in Natural Traits Using Model Organisms. Trends Genet 2018;34:883-98. [PMID: 30166071 DOI: 10.1016/j.tig.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Griesenbach U, Alton EW. Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction. F1000Prime Rep 2015;7:64. [PMID: 26097737 DOI: 10.12703/P7-64] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
22 Welsner M, Straßburg S, Taube C, Sutharsan S. Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case report. BMC Pulm Med 2019;19:76. [PMID: 30975115 DOI: 10.1186/s12890-019-0840-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Anglani F, Gianesello L, Beara-Lasic L, Lieske J. Dent disease: A window into calcium and phosphate transport. J Cell Mol Med 2019;23:7132-42. [PMID: 31472005 DOI: 10.1111/jcmm.14590] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
24 Magalhães M, Rivals I, Claustres M, Varilh J, Thomasset M, Bergougnoux A, Mely L, Leroy S, Corvol H, Guillot L, Murris M, Beyne E, Caimmi D, Vachier I, Chiron R, De Sario A. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis. Clin Epigenetics 2017;9:19. [PMID: 28289476 DOI: 10.1186/s13148-016-0300-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
25 Auslander N, Ramos DM, Zelaya I, Karathia H, Crawford TO, Schäffer AA, Sumner CJ, Ruppin E. The GENDULF algorithm: mining transcriptomics to uncover modifier genes for monogenic diseases. Mol Syst Biol 2020;16:e9701. [PMID: 33438800 DOI: 10.15252/msb.20209701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sánchez E, Azcona LJ, Paisán-Ruiz C. Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways. Mol Neurobiol 2018;55:6734-54. [PMID: 29344929 DOI: 10.1007/s12035-017-0846-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Palu RAS, Ong E, Stevens K, Chung S, Owings KG, Goodman AG, Chow CY. Natural Genetic Variation Screen in Drosophila Identifies Wnt Signaling, Mitochondrial Metabolism, and Redox Homeostasis Genes as Modifiers of Apoptosis. G3 (Bethesda) 2019;9:3995-4005. [PMID: 31570502 DOI: 10.1534/g3.119.400722] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
28 Palakuzhiyil SV, Christopher R, Chandra SR. Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy. World J Biol Chem 2020; 11(3): 99-111 [PMID: 33274015 DOI: 10.4331/wjbc.v11.i3.99] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Palu RAS, Chow CY. Baldspot/ELOVL6 is a conserved modifier of disease and the ER stress response. PLoS Genet 2018;14:e1007557. [PMID: 30081392 DOI: 10.1371/journal.pgen.1007557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
30 Carvajal G, Brukman NG, Weigel Muñoz M, Battistone MA, Guazzone VA, Ikawa M, Haruhiko M, Lustig L, Breton S, Cuasnicu PS. Impaired male fertility and abnormal epididymal epithelium differentiation in mice lacking CRISP1 and CRISP4. Sci Rep 2018;8:17531. [PMID: 30510210 DOI: 10.1038/s41598-018-35719-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
31 Lam CW, Wong KS, Leung HW, Law CY. Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations. Eur J Hum Genet 2017;25:192-9. [PMID: 27966543 DOI: 10.1038/ejhg.2016.162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]